Extensively Drug Resistant Shigella Rose from Zero to 8.5 Percent of US Samples in CDC Surveillance Data

CDC found XDR Shigella climbed from 0% to 8.5% of tested samples through 2023. No FDA-approved oral antibiotic treats it.

Have A Referral?